Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis

Open access
Yang, Haining, Bocchetta, Maurizio, Kroczynska, Barbara, Elmishad, Amira G., Chen, Yuanbin, Liu, Zemin, Bubici, Concetta, Mossman, Brooke T., Pass, Harvey I., Testa, Joseph R., Franzoso, Guido, Carbone, Michele · 2006 · Proceedings of the National Academy of Sciences

Abstract

Asbestos is the main cause of human malignant mesothelioma (MM). In vivo, macrophages phagocytize asbestos and, in response, release TNF-alpha and other cytokines that contribute to carcinogenesis through unknown mechanisms. In vitro, asbestos does not induce transformation of primary human mesothelial cells (HM); instead, asbestos is very cytotoxic to HM, causing extensive cell death. This finding raised an apparent paradox: How can asbestos cause MM if HM exposed to asbestos die? We found that asbestos induced the secretion of TNF-alpha and the expression of TNF-alpha receptor I in HM. Treatment of HM with TNF-alpha significantly reduced asbestos cytotoxicity. Through numerous technical approaches, including chemical inhibitors and small interfering RNA strategies, we demonstrate that, in HM, TNF-alpha activates NF-kappaB and that NF-kappaB activation leads to HM survival and resistance to the cytotoxic effects of asbestos. Our data show a critical role for TNF-alpha and NF-kappaB signaling in mediating HM responses to asbestos. TNF-alpha signaling through NF-kappaB-dependent mechanisms increases the percent of HM that survives asbestos exposure, thus increasing the pool of asbestos-damaged HM that are susceptible to malignant transformation. Cytogenetics supported this hypothesis, showing only rare, aberrant metaphases in HM exposed to asbestos and an increased mitotic rate with fewer irregular metaphases in HM exposed to both TNF-alpha and asbestos. Our findings provide a mechanistic rationale for the paradoxical inability of asbestos to transform HM in vitro, elucidate and underscore the role of TNF-alpha in asbestos pathogenesis in humans, and identify potential molecular targets for anti-MM prevention and therapy.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.0604008103

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 52 references

Research works printed but not linked: 12

  1. T. W. Hesterberg, C. J. Butterick, M. Oshimura, A. R. Brody, J. C. Barrett Cancer Res. 46, 5795–5802 (1986).
  2. N. Choe, S. Tanaka, W. Xia, D. R. Hemenway, V. L. Roggli, E. Kagan Environ. Health Perspect. 105, 1257–1260 (1997).
  3. K. E. Driscoll, J. M. Carter, D. G. Hassenbein, B. W. Howard Environ. Health Perspect. 105, 1159–1164 (1997).
  4. C. Xie, A. Reusse, J. Dai, K. Zay, J. Harnett, A. Churg Am. J. Physiol. 279, L608–L614 (2000).
  5. K. Donaldson, B. G. Miller, E. Sara, J. Slight, R. C. Brown Int. J. Exp. Pathol. 74, 243–250 (1993).
  6. M. Suganuma, S. Okabe, M. W. Marino, A. Sakai, E. Sueoka, H. Fujiki Cancer Res. 59, 4516–4518 (1999).
  7. M. Suganuma, S. Okabe, M. Kurusu, N. Iida, S. Ohshima, Y. Saeki, T. Kishimoto, H. Fujiki Int. J. Oncol. 20, 131–136 (2002).
  8. X. Hu, W. E. Janssen, L. C. Moscinski, M. Bryington, A. Dangsupa, N. Rezai-Zadeh, B. A. Babbin, K. S. Zuckerman Cancer Res. 61, 6290–6296 (2001).
  9. C. L. Scaife, J. Kuang, J. C. Wills, D. B. Trowbridge, P. Gray, B. M. Manning, E. J. Eichwald, R. A. Daynes, S. K. Kuwada Cancer Res. 62, 6870–6878 (2002).
  10. Y. M. Janssen, K. E. Driscoll, B. Howard, T. R. Quinlan, M. Treadwell, A. Barchowsky, B. T. Mossman Am. J. Pathol. 151, 389–401 (1997).
  11. S. Y. Tsai, B. Ardelt, T. C. Hsieh, Z. Darzynkiewicz, K. Shogen, J. M. Wu Int. J. Oncol. 25, 1745–1752 (2004).
  12. R. E. Rendall IARC Sci. Publ. 30, 87–96 (1980).

Cited by

See all 361

Metadata

Authors
Yang, H., Bocchetta, M., Kroczynska, B., Elmishad, A. G., Chen, Y., Liu, Z., Bubici, C., Mossman, B. T., Pass, H. I., Testa, J. R., Franzoso, G., & Carbone, M.
Affiliations
  • Loyola University Chicago (US)
  • *Thoracic Oncology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL 60153;
  • Fox Chase Cancer Center (US)
  • University of Chicago (US)
  • University of Vermont (US)
  • New York University (US)
Venue
Proceedings of the National Academy of Sciences
Published
2006-07-05
Volume
103
Issue
27
Pages
10397-10402
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1985690846
Cited by
322
References
52
Citations by year
2026: 5 · 2025: 8 · 2024: 9 · 2023: 20 · 2022: 26 · 2021: 21 · 2020: 12 · 2019: 11 · 2018: 6 · 2017: 13 · 2016: 11 · 2015: 16 · 2014: 17 · 2013: 19 · 2012: 22
FWCI
19.14
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (7r01ca092657-06, 5p01ca114047-05)
  • National Cancer Institute (R01-CA092657, R01CA106567, P01CA-114047)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
asbestos, TNF-α, NF-κB signaling, malignant mesothelioma, mesothelial cells, macrophage phagocytosis, malignant transformation, mitotic aberrations
MeSH terms
Asbestos, Cell Transformation, Neoplastic, Cells, Cultured, Chromosomes, Human, Epithelium, Humans, Metaphase, Tumor Necrosis Factor-alpha, Signal Transduction, NF-kappa B, RNA Interference, Receptors, Tumor Necrosis Factor, Type I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. https://app.cochat.ai/papers/10.1073/pnas.0604008103
The paper
Yang, H., Bocchetta, M., Kroczynska, B., Elmishad, A. G., Chen, Y., Liu, Z., Bubici, C., Mossman, B. T., Pass, H. I., Testa, J. R., Franzoso, G., & Carbone, M. (2006). TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0604008103

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.